Indian equities ended higher on Tuesday, supported by easing geopolitical tensions and softer crude prices. A sharp drop in India VIX boosted sentiment, while broader markets outperformed. Analysts see potential for further recovery, though caution persists amid FII outflows, global uncertainties and weak near-term earnings outlook.
Private equity firm BC Investments IV sold a Rs 612 crore stake in Emcure Pharmaceuticals to Kotak Mahindra Mutual Fund at Rs 1,700 per share. Despite this divestment, analysts remain positive on Emcure's growth outlook across its core therapeutic segments.
Domestic markets are showing signs of recovery after recent declines, aided by easing geopolitical tensions and softer crude prices. However, volatility persists due to FII outflows and global uncertainties. Analysts recommend CCL Products and CMPDI, citing strong technical setups, positive momentum and bullish chart patterns.
Pride Hotels Limited is thrilled to announce the addition of a new 141-key hotel in the vibrant city of Indore, Madhya Pradesh. This exciting launch marks the fifth Plaza Hotel under the group's umbrella, reinforcing their dedication to providing top-notch hospitality.
Studds Accessories shares soared 18.3% to a 13-week high after reports of a sharp rise in helmet demand in West Bengal following stricter traffic-rule enforcement. The company reported strong sales growth, expects organised players to gain market share, and is expanding capacity to meet rising demand.
CrowdStrike experienced a stark decline in its share prices on Thursday, largely attributed to its quarterly guidance that failed to impress investors. Nevertheless, the cybersecurity software landscape remains vibrant, fueled by significant strides in AI technology. Observers note that some investors opted to realize gains after the stock's upward momentum.
The government's offer for sale in NLC India saw strong demand on the first day. Non-retail investors bid for shares worth Rs 4,158 crore. This indicates significant interest in the disinvestment. The offer is open for retail investors today. The government aims to raise funds through this stake sale. This is part of its broader PSU disinvestment strategy.
A promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund acquiring the stake. The transaction comes amid strong earnings growth, healthy margins and sustained momentum in the company’s pharmaceutical business.
MF Performance
Major Indices
